Effects of chlormadinone acetate (CMA) in endometrium (Laboratory study)

• Conditions: N94.4; Primary dysmenorrhoea

• Registration Number: DRKS00009458
• Lead Sponsor: Gedeon Richter Plc.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-10-15
• Study Completion: 2017-03-16
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 31

Inclusion Criteria

Women in reproductive age with regular menstrual cycle

Exclusion Criteria

Pregnancy, postmenopause, gynecological cancer, hormonal treatment within the last 3 months, vaginal bleeding of unknown origin, vaginal infections, major uterine scarring, uterine atrophy

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br>CMA effects on endometrial Arachidonic acid cascade in comparison to other progestins